Sulthiame shows promise in reducing obstructive sleep apnea symptoms

Patients taking sulthiame, a drug currently in use for epilepsy, experienced a reduction in their symptoms of obstructive sleep apnoea (OSA), according to results of a clinical trial presented at the European Respiratory Society (ERS) Congress in Vienna, Austria.

Liver’s defense mechanism hinders immunity in chronic hepatitis B, study reveals

In chronic hepatitis B, the liver contains immune cells that could destroy hepatitis B virus infected cells but are inactive. A team from the Technical

July 11, 2024

Scientists Show How Pregnancy Changes the Brain in Innumerable Ways

Neuroscientist Liz Chrastil, PhD, got the unique chance to see how her brain changed while she was pregnant and share what she learned in a

September 17, 2024

Penn Medicine Pulls Out of U.S. News Hospital Rankings

The pushback regarding U.S. News & World Report’s rankings continues to grow. Earlier this year, following many medical schools forgoing participation in the rankings, a

June 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.